Welcome to YLOAN.COM
yloan.com » emc » Pulmonary Arterial Hypertension (pah) - Drug Pipeline Analysis And Market Forecasts To 2016
filter emc

Pulmonary Arterial Hypertension (pah) - Drug Pipeline Analysis And Market Forecasts To 2016

Summary

Summary

It is the industry analysis specialists new report, Pulmonary Arterial Hypertension (PAH) - Drug Pipeline Analysis and Market Forecasts to 2016"" is an essential source of information and analysis on the global PAH market, a key segment within the pharmaceutical and healthcare industry. This pharma report identifies the key trends shaping and driving the global PAH market. The report also provides insight on the prevalent competitive landscape and the emerging players expected to bring significant shift in the market positioning of the existing market leaders. Most importantly, the report provides valuable insight on the pipeline products within the global PAH sector.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in house analysis by its team of industry experts.

Scope

The scope of the report includes:

- Annualized global PAH market revenues data from 2005 to 2009, forecast forward for seven years to 2016.

- Geographic markets covered in this report include the US, the UK, Italy, Spain, Germany, France, and Japan.

- Pipeline analysis data provides a split across different phases, mechanism of actions being developed and emerging trends. Key classes of mechanism of action include endothelin receptor antagonists, platelet aggregation inhibitors, phosphodiesterase inhibitors, serotonin pathway antagonists, angiotensin receptor antagonists, P2Y 12 receptor inhibitors, PDE5 inhibitors, prostacyclin (PGI2) agonists, nitric oxide synthetase inhibitors.

- Analysis of the current and future market competition in the global PAH market. Key market players covered are Actelion Ltd.,United Therapeutics Corporation, Bayer AG, Gilead Sciences, Pfizer Inc., Novartis AG, Bristol-Myers Squibb, Sanofi-Aventis, Eli Lilly and Company, Lung RX and GlaxoSmithKline Plc.

- Insightful reviews of the key industry drivers, restraints and challenges. Each trend is independently researched to provide qualitative analysis of its implications.

- Key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for the future market associated with PAH.

For more information, please visit:

http://www.aarkstore.com/reports/Pulmonary-Arterial-Hypertension-PAH-Drug-Pipeline-Analysis-and-Market-Forecasts-to-2016-37972.html

Or email us at press@aarkstore.com or call +919272852585

Aarkstore Enterprise

Tel : +912227453309

Mobile No: +919272852585

Email : contact@aarkstore.com

Website : http://www.aarkstore.com

Blog: http://blogs.aarkstore.com/

Follow us on twitter: http://twitter.com/aarkstoredotcom

by:Aarkstore Enterprise
Spectrum Of Elements In Appraisal Of Boys Boarding School Why Pure Water Gives Clear Results In The Laboratory How Laboratory Mills Are Used On Different Materials Why Laboratory Mills Aid Accurate Results Atlantic Toyota and Huntington Toyota Customers Hear Toyota Corp Earns Eight Top Safety Pick Awards Exclusive And Elite, Scottsdale Fashion Square Is The Shopaholics Paradise! Four home appliances store drums sounded the confidentiality of marketing programs The Polyethylene Terephthalate PET Market to 2020 Carbonated Soft Drinks and Bottled Water Market in Asia Driving the Global Demand How Do I Maintain My Home Appliances? The Trendiest, Classy And Stylish Latest Electronic Gadgets Abbott Laboratories recalls glucose test strips How To Search For Brugte Yamaha Pahængsmotorer Put For Sale Printed Circuit Board Manufacturing And Pcb Manufacturers Importance
print
www.yloan.com guest:  register | login | search IP(216.73.216.35) California / Anaheim Processed in 0.018042 second(s), 7 queries , Gzip enabled , discuz 5.5 through PHP 8.3.9 , debug code: 43 , 2870, 953,
Pulmonary Arterial Hypertension (pah) - Drug Pipeline Analysis And Market Forecasts To 2016 Anaheim